Google Académico | Citações: 16429 | índice h: 32 | índice i10: 482
Análisis evolutivo del tratamiento de las úlceras neuropáticas en pie diabético
PDF (portugués (Brasil))

Palabras clave

Neuropatías diabéticas
Tratamiento
Medicina

Cómo citar

Análisis evolutivo del tratamiento de las úlceras neuropáticas en pie diabético. (2025). Revista Eletrônica Acervo Saúde, 25, e19233. https://doi.org/10.25248/reas.e19233.2025

Copyright © | Todos los derechos reservados.

La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.

Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.

Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.

Resumen

Objetivo: Identificar los principales puntos evolutivos en cuanto al tratamiento de las úlceras neuropáticas en pie diabético en los últimos 5 años. Métodos: Se trata de una revisión integradora de carácter descriptivo con artículos publicados entre 2019 y 2024, en inglés y español, con texto completo disponible. Se utilizó la pregunta orientadora: ¿Cuáles son las nuevas opciones terapéuticas para el tratamiento de las úlceras neuropáticas en lesiones en los pies de personas con diabetes? Los artículos fueron recopilados utilizando las bases de datos PubMed y Scielo. Los descriptores fueron: “Úlcera Neuropática”, “Pie Diabético”, “Tratamiento”, “Medicina”, “Paciente”, totalizando 40 artículos encontrados. Resultados: La investigación apunta a fuertes evidencias sobre la efectividad del tratamiento con el Factor de Crecimiento Epidérmico Recombinante (HRGF), por lo que es necesario demostrar efectivamente los resultados del estudio realizado en Brasil. Como medicamento ya en uso, destaca el ácido alfa lipoico, por sus propiedades antioxidantes. Para el tratamiento del dolor neuropático, el uso de capsaicina es eficaz para mejorar la calidad de vida del paciente. Consideraciones finales: Se considera que las nuevas presentaciones terapéuticas descritas en el estudio han contribuido a la caída global del número de amputaciones en los últimos años.

PDF (portugués (Brasil))

Referencias

AMARA F, et al. Review of Diabetic Polyneuropathy: Pathogenesis, Diagnosis and Management According to the Consensus of Egyptian Experts. Curr Diabetes Rev, 2019; 15(4): 340-345.

ATLAS, Diabetes et al. International diabetes federation. IDF Diabetes Atlas, 7th edn. Brussels, Belgium: International Diabetes Federation, 2022; 33: 2.

BOBIRCA F, et al. The Outcome of Surgical Treatment for the Neuropathic Diabetic Foot Lesions-A Single-Center Study. Life (Basel), 2022; 12(8): 1156.

CASTANEIRA J, et al. Recidiva de úlcera del pie en pacientes diabéticos tratados con Heberprot-P®. Rev Cubana Angiol Cir Vasc, 2020; 21(2).

CHANDLER LA, et al. Wound Conforming Matrix Containing Purified Homogenate of Dermal Collagen Promotes Healing of Diabetic Neuropathic Foot Ulcers: Comparative Analysis Versus Standard of Care. Adv Wound Care, 2020; 9(2): 61-67.

CONFORTO EC, et al. Roteiro para revisão bibliográfica sistemática: aplicação no desenvolvimento de produtos e gerenciamento de projetos. Gestão de Desenvolvimento de Produtos, 2011; 8: 1-12.

DADFAR R, et al. Therapeutic Utilization of Zinc Supplementation Concurrent with Ozone Therapy Ameliorates Diabetic Foot Ulcer and Attenuates Serum Level of C-reactive Protein- A Case Report Study. Adv Biomed Res, 2023; 12: 18.

D'AMICO M, et al. Data-driven CAD-CAM vs traditional total contact custom insoles: A novel quantitative-statistical framework for the evaluation of insoles offloading performance in diabetic foot. PLoS One, 2021; 16(3): 247915.

DE LIMA AEF, et al. Ozonioterapia como opção ao tratamento de lesões cutâneas em humanos: revisão integrativa da literatura. Arquivos de Ciências da Saúde da UNIPAR, 2022; 26(3): 233-242.

DLUDLA PV, et al. Capsaicin, its clinical significance in patients with painful diabetic neuropathy. Biomed Pharmacother, 2022; 153: 113439.

ESCALANTE P, et al. Factores pronósticos de amputación mayor en pacientes con pie diabético sometidos a cirugía. Rev Cubana Angiol Cir Vasc, 2020; 21(3).

GARCIA H e ARÍSTIDES L. Procedimientos quirúrgicos del pie diabético neuropático. Rev Cubana Angiol Cir Vasc, 2020; 21(2).

GUERRIERO FP, et al. Overcoming Barriers to Wound Healing in a Neuropathic and Neuro-Ischaemic Diabetic Foot Cohort Using a Novel Bilayer Biodegradable Synthetic Matrix. Biomedicines, 2023; 11(3): 721.

HAMMER GD e MCPHEE SJ. Fisiopatologia da doença. McGraw Hill Brasil, 2015; 784.

HASSANZADEH S, et al. Effectiveness of oral clonidine and gabapentin on peripheral neuropathy in diabetic patients in southwestern Iran: a randomized clinical trial. BMC Endocr Dis, 2023; 23(1): 224.

HASTINGS MK, et al. Qualitative study of musculoskeletal tissues and their radiographic correlates in diabetic neuropathic foot deformity. Foot (Edinb), 2021; 47: 101777.

HUSSAIN N, et al. The efficacy and safety profile of capsaicin 8% patch versus 5% Lidocaine patch in patients with diabetic peripheral neuropathic pain: a randomized, placebo-controlled study of south Asian male patients. J Diabetes Metab Disord, 2021; 20(1): 271-278.

JESUS BM. Eficácia da Terapia de Pressão Negativa no Pé Diabético. Dissertação de Mestrado. Universidade da Beira Interior (Portugal), 2021; 36.

KALAN LR, et al. Strain-and Species-Level Variation in the Microbiome of Diabetic Wounds Is Associated with Clinical Outcomes and Therapeutic Efficacy. Cell Host Microbe, 2019; 25(5): 641-6555.

LAZZARINI PA, et al. Effectiveness of offloading interventions to heal foot ulcers in persons with diabetes: a systematic review. Diabetes Metab Res Rev, 2020; 36(1): 3275.

MARTINEZ GI e RODRIGUEZ RY. Úlcera del pie diabético tratado con Heberprot-p®. Rev Cubana Angiol Cir Vasc, 2020; 21(1).

MEIMETI E, et al. Marine Isopod Ceratothoa Oestroides Extract: a Novel Treatment for Diabetic Foot Ulcers? Case Report of an Immunosuppressed Patient. Med Arch, 2019; 73(2): 131-133.

MENS MA, et al. Biomechanical and musculoskeletal changes after flexor tenotomy to reduce the risk of diabetic neuropathic toe ulcer recurrence. Diabet Med, 2022; 39(4): 14761.

MEYROWITZ HN, et al. Venous, Arterial, and Neuropathic Leg Ulcers With Emphasis on the Geriatric Population. Cureus, 2023; 15(4): 38123.

MIN KR, et al. Association between baseline abundance of Peptoniphilus, a Gram-positive anaerobic coccus, and wound healing outcomes of DFUs. PLoS One, 2020; 15(1): 227006.

MONTEIRO RL, et al. Protocol for evaluating the effects of a foot-ankle therapeutic exercise program on daily activity, foot-ankle functionality, and biomechanics in people with diabetic polyneuropathy: a randomized controlled trial. BMC Musculoskelet Disord, 2018; 19(1): 400.

NAMGOONG S, et al. A Pilot Study Comparing a Micronized Adipose Tissue Niche versus Standard Wound Care for Treatment of Neuropathic Diabetic Foot Ulcers. J Clin Med, 2022; 11(19): 5887.

PORTH CM e MATFIN G. Fisiopatologia. In: Fisiopatologia, 2021; 911-911.

PUTZ Z, et al. Vitamin D in the Prevention and Treatment of Diabetic Neuropathy. Clin Ther, 2022; 44(5): 813-823.

REEVES ND,et al. Sensory-Motor Mechanisms Increasing Falls Risk in Diabetic Peripheral Neuropathy. Medicina, 2021; 57(5): 457.

RUIZ-TOLEDO J, et al. Evaluation of the Complementary Health Provision of the Podiatric Foot Care Program for Diabetic Patients in Catalonia (Spain). Int J Environ Res Public Healt, 2021; 18(10): 5093.

SOCIEDADE BRASILEIRA DE DIABETES. Diretrizes da Sociedade Brasileira de Diabetes 2019-2020, 2022; 8(2): 178-180.

SORIA B, et al. Cell Therapy of Vascular and Neuropathic Complications of Diabetes: Can We Avoid Limb Amputation? Int J Mol Sci, 2023; 24(24): 17512.

SYABARIYAH S, et al. The Effect of Vibration on the Acceleration of Wound Healing of Diabetic Neuropathic Foot Ulcer: A Prospective Experimental Study on Human Patients. Healthcare, 2023; 11(2): 191.

TANG F, et al. Fast-Access Multidisciplinary Approach to Management of Diabetic Foot Ulcers: The Diabetic Rapid Evaluation and Lower Limb Amputation Management (DREAM) Clinic. Clin Med Insights Endocrinol Diabetes, 2023; 16: 11795514231196464.

WALKER CA, et al. Hospitalists' Needs Assessment and Perceived Barriers in Wound Care Management: A Quality Improvement Project. J Wound Ostomy Continence Nurs, 2019; 46(2): 98-105.

YANG H, et al. New Perspective in Diabetic Neuropathy: From the Periphery to the Brain, a Call for Early Detection, and Precision Medicine. Front Endocrinol (Lausanne), 2020.

ZIEGLER D, et al. Current concepts in the management of diabetic polyneuropathy. J Diabetes Investig, 2021; 12(4): 464-475.

ZIEGLER D, et al. Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations. Diabetes Res Clin Pract, 2022; 186: 109063.

ZWAFERINK JBJ, et al. Optimizing footwear for the diabetic foot: Data-driven custom-made footwear concepts and their effect on pressure relief to prevent diabetic foot ulceration. PLoS One, 2020; 15(4): 224010.